PHASE 3 STUDY OF SAFETY AND IMMUNOGENICITY OF GBP510 VACCINE ADJUVANTED WITH AS03 IN ADULTS

INTRO: GBP510 contains the self-assembling recombinant nanoparticle displaying SARS‐CoV-2 Spike protein receptor binding domain and is adjuvanted with AS03. We report interim Phase 3 study (NCT05007951) results up to 4 weeks post-dose 2 (Data-cut: March-18-2022), where immunogenicity to the D614G an...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, J.Y., Choi, W.S., Cheong, H.J., Kim, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186949/
http://dx.doi.org/10.1016/j.ijid.2023.04.344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186949/
http://dx.doi.org/10.1016/j.ijid.2023.04.344

Ejemplares similares